Interestingly, venetoclax plus ATO in our APL cell models exerted synergistic cytotoxic effects in the ATO-resistant clone showing the highest BCL2 basal levels (CL2-R). The gene discussed is BCL2; the disease is acute promyelocytic leukemia.